Farace P.; Galiè M.; Nanni C.; Spinelli A.; Fanti S., Contouring carcinomas by FDG-PET: is the role of tumor biology underestimated? In regard to MacManus et al. (Int J Radiat Oncol Biol Phys 2008;71:2-4)., «INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS», 2008, 72, pp. 303 - 304 [replica/breve intervento]
Pantaleo M.A.; Nannini M.; Maleddu A.; Fanti S.; Ambrosini V.; Nanni C.; Boschi S.; Biasco G., Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy.
Review, «CANCER TREATMENT REVIEWS», 2008, 34, pp. 103 - 121 [articolo]
Nanni C; Rubello D; Fanti S., Could choline PET play a role in malignancies other than prostate cancer?, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2008, 35, pp. 216 - 218 [replica/breve intervento]
Magini G, Frigerio M, Farsad M, Serra C, Colecchia A, Jovine E, Vivarelli M, Feletti V, Golfieri R, Lodi F, Franchi R, Fanti S, Bernardi M, Trevisani F, Differential diagnosis between focal nodular hyperplasia and hepatocellular adenoma: Potential role of double tracer PET with 11C-Acetate and 18F-FDG, «JOURNAL OF HEPATOLOGY», 2008, 48, pp. 153 - 153 [abstract]
Fanti S.; Castellucci P.; Stefoni V.; Nanni C.; Tani M.; Rubello D.; Ambrosini V.; Zinzani P.L.; Franchi R., Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET., «ANNALS OF NUCLEAR MEDICINE», 2008, 22(5), pp. 429 - 432 [articolo]
Fanti S.; Ambrosini V.; Tomassetti P.; Castellucci P.; Montini G.; Allegri V.; Grassetto G.; Rubello D.; Nanni C.; Franchi R., Evaluation of unusual neuroendocrine tumours by means of (68)Ga-DOTA-NOC PET., «BIOMÉDECINE & PHARMACOTHÉRAPIE», 2008, 62(10), pp. 667 - 671 [articolo]
Zinzani PL; Tani M; Pulsoni A; Gobbi M; Perotti A; De Luca S; Fabbri A;
Zaccaria A; Voso MT; Fattori P; Guardigni L; Ronconi S; Cabras MG; Rigacci L; De Renzo A; Marchi E; Stefoni V; Fina M; Pellegrini C; Musuraca G; Derenzini E; Pileri S; Fanti S; Piccaluga PP; Baccarani M., Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ)., «THE LANCET ONCOLOGY», 2008, 9, pp. 352 - 358 [articolo]
Ambrosini V.; Rubello D.; Nanni C.; Al-Nahhas A.; Fanti S., Ga-68-DOTA-peptides versus F-18-DOPA PET for the assessment of NET patients, «NUCLEAR MEDICINE COMMUNICATIONS», 2008, 29, pp. 415 - 417 [articolo]
Pantaleo MA;Nannini M;Lopci E;Castellucci P;Maleddu A;Lodi F;Nanni C;Allegri V;Astorino M;Brandi G;Di Battista M;Boschi S;Fanti S;Biasco G, Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases., «INTERNATIONAL JOURNAL OF ONCOLOGY», 2008, 33, pp. 443 - 452 [articolo]
Brandi G; Nannini M; Pantaleo MA; Fanello S; Farsad M; Fanti S; Ercolani G; Maleddu A; Di Battista M; Biasco G., Molecular imaging suggests efficacy of bevacizumab beyond the second line in advanced colorectal cancer patients., «CHEMOTHERAPY», 2008, 54(6), pp. 421 - 424 [articolo]
Kumar R; Dhanpathi H; Basu S; Rubello D; Fanti S; Alavi A., Oncologic PET tracers beyond [18F]FDG and the novel quantitative approaches in PET imaging., «THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2008, 52(1), pp. 50 - 65 [articolo]
Alavi A.; Fanti S., PET imaging in endocrine disorders
PET clinics, PHILADELPHIA, W.B. Saunders Company, 2008, pp. 240 (Elsevier). [libro]
Prasad V.; Ambrosini V.; Alavi A.; Fanti S.; Baum R.P., PET/CT in Neuroendocrine Tumors: evaluation of receptor status and metabolism, in: TORIGIAN D.A. ALAVI A., PET/CT and PET/MRI for assessment of structural and functional Relationships in Disease Conditions, PHILADELPHIA, W.B. Sauders Company, 2008, pp. 355 - 379 [capitolo di libro]
Farsad M; Schiavina R; Franceschelli A; Sanguedolce F; Castellucci P; Bertaccini A; Brunocilla E; Manferrari F; Concetti S; Garofalo M; Rocca C; Borghesi M; Franchi R; Fanti S; Nanni C; Martorana G., POSITRON-EMISSION TOMOGRAPHY IN IMAGING AND STAGING PROSTATE CANCER, «DISEASE MARKERS. SECTION A, CANCER BIOMARKERS», 2008, 4, pp. 277 - 284 [articolo]
Derenzini E; Musuraca G; Fanti S; Stefoni V; Tani M; Alinari L; Venturini F; Gandolfi L; Baccarani M; Zinzani PL., Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma., «CANCER», 2008, 113(9), pp. 2496 - 2503 [articolo]
